You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 2926 to 2950 of about 5897
Next 25
09/26/2010
Amgen Initiates Voluntary Nationwide Recall of Certain Lots Of Epogen® And Procrit® (Epoetin Alfa)
09/25/2010
Call for Entries for the 2011 Neuro Film Festival
09/24/2010
Childhood Cancer Survivors Show Sustained Benefit From Common ADHD Medication
09/23/2010
Selective Serotonin Reuptake Inhibitors, Glioblastoma Multiforme, and Impact on Toxicities and Overall Survival: The Mayo Clinic Experience.
09/21/2010
New vaccine trial at UCLA opens - for newly diagnosed or recurrent GBMs, Anaplastic Astrocytoma, and other brain tumor types!
09/18/2010
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: Is there a difference in outcome between morning and afternoon treatment?
09/16/2010
The nontoxic natural compound Curcumin exerts anti-proliferative, anti-migratory, and anti-invasive properties against malignant gliomas.
09/13/2010
An update to Ben Williams paper that was recently posted - to correct an error in the section on Novocure
09/12/2010
Update of Ben William`s excellent 116 page article on treatment options for glioblastoma and other gliomas!
09/09/2010
“Living With a Brain Tumor - A Conference for Patients and Families”
09/08/2010
UTAH MOM OF FIVE COMES THROUGH BRAIN SURGERY WITH HER HEARING AND HER SMILE
“Talking With Your Children About Brain Tumors “
09/04/2010
ImmunoCellular Therapeutics Issues Letter to Shareholders
09/03/2010
Surgeons Use New Tools to Treat Inoperable Brain Tumors
Celldex, Pfizer Split Over Brain Tumor Drug
08/29/2010
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma.
Poor drug distribution as a possible explanation for the results of the PRECISE trial.
Accumulation o f CD133-positive glioma cells after high-dose irradiation by Gamma Knife surgery plus external beam radiation.
08/17/2010
ImmunoCellular Therapeutics Announces 2010 Second Quarter Results (And reports 100% 1 year survival!)
Moores UCSD Cancer Center Brain Tumor Treatment Program Launches Biomarker Clinical Study
Added new trial: A Phase II Study of PDGFR Kinase Inhibitor (Tasigna® - nilotinib) in Biomarker-Enriched Recurrent Malignant Gliomas
08/15/2010
First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a mu lticenter experience.
A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma.
Repeated treatments with bevacizumab for recurrent radiation necrosis in patients with malignant brain tumors: a report of 2 cases.
08/13/2010
IBTA E News